One hundred and fifty patients with advanced cancer participated in a controlled double-blind study to evaluate the effects of high-dose vitamin C on symptoms and survival. Patients were divided randomly into a group that received vitamin C (10 g per day) and one that received a comparably flavored lactose placebo. Sixty evaluable patients received vitamin C and 63 received a placebo. Both groups were similar in age, sex, site of primary tumor, performance score, tumor grade and previous chemotherapy. The two groups showed no appreciable difference in changes in symptoms, performance status, appetite or weight. The median survival for all patients was about seven weeks, and the survival curves essentially overlapped. In this selected group of patients, we were unable to show a therapeutic benefit of high-dose vitamin C treatment.
This article has been cited by other articles:
Du, J., Martin, S. M., Levine, M., Wagner, B. A., Buettner, G. R., Wang, S.-h., Taghiyev, A. F., Du, C., Knudson, C. M., Cullen, J. J.
(2010). Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer. Clin. Cancer Res.
16: 509-520
[Abstract][Full Text]
OHNO, S., OHNO, Y., SUZUKI, N., SOMA, G.-I., INOUE, M.
(2009). High-dose Vitamin C (Ascorbic Acid) Therapy in the Treatment of Patients with Advanced Cancer. Anticancer Res
29: 809-815
[Abstract][Full Text]
Sharifi, N.
(2009). Commentary: Antioxidants for Cancer: New Tricks for an Old Dog?. The Oncologist
14: 213-215
[Abstract][Full Text]
Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., Levine, M.
(2008). From the Cover: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA
105: 11105-11109
[Abstract][Full Text]
Frei, B., Lawson, S.
(2008). Vitamin C and cancer revisited. Proc. Natl. Acad. Sci. USA
105: 11037-11038
[Full Text]
Legg, J.
(2008). What is Evidence-based Practice?. radtech
79: 469-471
[Full Text]
Cassileth, B. R., Deng, G. E., Gomez, J. E., Johnstone, P. A. S., Kumar, N., Vickers, A. J.
(2007). Complementary Therapies and Integrative Oncology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest
132: 340S-354S
[Abstract][Full Text]
Chen, Q., Espey, M. G., Sun, A. Y., Lee, J.-H., Krishna, M. C., Shacter, E., Choyke, P. L., Pooput, C., Kirk, K. L., Buettner, G. R., Levine, M.
(2007). Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl. Acad. Sci. USA
104: 8749-8754
[Abstract][Full Text]
Davies, A. A., Davey Smith, G., Harbord, R., Bekkering, G. E., Sterne, J. A. C., Beynon, R., Thomas, S.
(2006). Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review.. JNCI J Natl Cancer Inst
98: 961-973
[Abstract][Full Text]
Padayatty, S. J., Riordan, H. D., Hewitt, S. M., Katz, A., Hoffer, L. J., Levine, M.
(2006). Intravenously administered vitamin C as cancer therapy: three cases.. CMAJ
174: 937-942
[Abstract][Full Text]
Assouline, S., Miller, W. H.
(2006). High-dose vitamin C therapy: renewed hope or false promise?. CMAJ
174: 956-957
[Full Text]
Moss, R. W.
(2006). Should Patients Undergoing Chemotherapy and Radiotherapy Be Prescribed Antioxidants?. Integr Cancer Ther
5: 63-82
[Abstract]
Vickers, A. J., Kuo, J., Cassileth, B. R.
(2006). Unconventional Anticancer Agents: A Systematic Review of Clinical Trials. JCO
24: 136-140
[Abstract][Full Text]
Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., Shacter, E., Levine, M.
(2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA
102: 13604-13609
[Abstract][Full Text]
D'Andrea, G. M.
(2005). Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided. CA Cancer J Clin
55: 319-321
[Abstract][Full Text]
Hathcock, J. N, Azzi, A., Blumberg, J., Bray, T., Dickinson, A., Frei, B., Jialal, I., Johnston, C. S, Kelly, F. J, Kraemer, K., Packer, L., Parthasarathy, S., Sies, H., Traber, M. G
(2005). Vitamins E and C are safe across a broad range of intakes. Am. J. Clin. Nutr.
81: 736-745
[Abstract][Full Text]
Gonzalez, M. J., Miranda-Massari, J. R., Mora, E. M., Guzman, A., Riordan, N. H., Riordan, H. D., Casciari, J. J., Jackson, J. A., Roman-Franco, A.
(2005). Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later. Integr Cancer Ther
4: 32-44
[Abstract]
Mayland, C. R, Bennett, M. I, Allan, K.
(2005). Vitamin C deficiency in cancer patients. Palliat Med
19: 17-20
[Abstract]
Padayatty, S. J., Sun, H., Wang, Y., Riordan, H. D., Hewitt, S. M., Katz, A., Wesley, R. A., Levine, M.
(2004). Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use. ANN INTERN MED
140: 533-537
[Abstract][Full Text]
Vickers, A.
(2004). Alternative Cancer Cures: "Unproven" or "Disproven"?. CA Cancer J Clin
54: 110-118
[Abstract][Full Text]
Ladas, E. J., Jacobson, J. S., Kennedy, D. D., Teel, K., Fleischauer, A., Kelly, K. M.
(2004). Antioxidants and Cancer Therapy: A Systematic Review. JCO
22: 517-528
[Abstract][Full Text]
Cassileth, B. R., Deng, G.
(2004). Complementary and Alternative Therapies for Cancer. The Oncologist
9: 80-89
[Abstract][Full Text]
Block, K. I., Mead, M. N.
(2003). Vitamin C in Alternative Cancer Treatment: Historical Background. Integr Cancer Ther
2: 147-154
[Abstract]
Drisko, J. A., Chapman, J., Hunter, V. J.
(2003). The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer. J. Am. Coll. Nutr.
22: 118-123
[Abstract][Full Text]
Weiger, W. A., Smith, M., Boon, H., Richardson, M. A., Kaptchuk, T. J., Eisenberg, D. M.
(2002). Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer. ANN INTERN MED
137: 889-903
[Abstract][Full Text]
Prasad, K. N., Cole, W. C., Kumar, B., Prasad, K. C.
(2001). Scientific Rationale for Using High-Dose Multiple Micronutrients as an Adjunct to Standard and Experimental Cancer Therapies. J. Am. Coll. Nutr.
20: 450S-463
[Abstract][Full Text]
Markman, M.
(2001). Interactions Between Academic Oncology and Alternative/Complementary/Integrative Medicine: Complex But Necessary. JCO
19: 52s-53
[Full Text]
Dickerson, J. W. T.
(2001). Aspects of the history of nutrition since 1876. The Journal of the Royal Society for the Promotion of Health
121: 79-84
[Abstract]
Hoffer, L. J.
(2001). Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies. CMAJ
164: 351-353
[Full Text]
Padayatty, S. J., Levine, M.
(2001). New insights into the physiology and pharmacology of vitamin C. CMAJ
164: 353-355
[Full Text]
Padayatty, S. J, Levine, M.
(2000). Reevaluation of Ascorbate in Cancer Treatment: Emerging Evidence, Open Minds and Serendipity. J. Am. Coll. Nutr.
19: 423-425
[Abstract][Full Text]
Cassileth, B. R.
(1999). Complementary and Alternative Cancer Medicine. JCO
17: 44-52
[Full Text]
Prasad, K. N., Kumar, A., Kochupillai, V., Cole, W. C.
(1999). High Doses of Multiple Antioxidant Vitamins: Essential Ingredients in Improving the Efficacy of Standard Cancer Therapy. J. Am. Coll. Nutr.
18: 13-25
[Abstract][Full Text]
Council on Scientific Affairs,
(1987). Vitamin Preparations as Dietary Supplements and as Therapeutic Agents. JAMA
257: 1929-1936
[Abstract]
Dickerson, J.W.T.
(1986). Does Diet Cure Cancer?. The Journal of the Royal Society for the Promotion of Health
106: 191-193
Lawton, J. M., Conway, L. T., Crosson, J. T., Smith, C. L., Abraham, P. A.
(1985). Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration. Arch Intern Med
145: 950-951
[Abstract]
Herbert, V.
(1980). The Vitamin Craze. Arch Intern Med
140: 173-176
[Abstract]
Regelson, W.
(1980). The 'Grand Conspiracy' Against the Cancer Cure. JAMA
243: 337-339
[Abstract]
Previous
